Laxative by Northeast Pharma / LNK International, Inc. hpc 441
Laxative by
Drug Labeling and Warnings
Laxative by is a Otc medication manufactured, distributed, or labeled by Northeast Pharma, LNK International, Inc.. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
LAXATIVE- bisacodyl tablet, delayed release
Heartland Pharma Co.
----------
hpc 441
Uses
- for relief of occasional constipation and irregularity
- this product generally produces bowel movement in 6 to 12 hours
Warnings
Do not use if you cannot swallow without chewing
Ask a doctor before use if you have
stomach pain, nausea, vomiting
noticed a sudden change in bowel habits that lasts more than 2 weeks
When using this product do not chew or crush tablet(s)
do not use within 1 hour after taking an antacid or milk
it may cause stomach discomfort, faintness and cramps
Stop use and ask a doctor if you have rectal bleeding or no
bowel movement after using this product.
These could be signs of a serious condition.
you need to use a laxative for more than 1 week
If pregnant or breast-feeding, ask a health professional before use.
Directions
- take with a glass of water
- do not take more than directed
| adults and children
12 years of age and over | 1-3 tablets in a
single daily dose |
| children 6 to under
12 years of age | 1 tablet in a single
daily dose |
| children under
6 years of age | ask a doctor |
Other information
- store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted between 15º-30ºC (59º-86ºF)
- avoid excessive humidity
- package not child resistant
Inactive ingredients
acacia, ammonium hydroxide,
calcium carbonate, corn starch, D&C yellow #10 lake,
FD&C yellow #6 lake, hypromellose, iron oxide black, lactose,
magnesium stearate, methylparaben, PEG, polydextrose,
polyvinyl acetate phthalate, propylparaben, propylene glycol,
povidone, shellac, simethicone, silica, sodium alginate,
sodium benzoate, sodium bicarbonate, stearic acid, sucrose,
talc, titanium dioxide, triacetin, triethyl citrate, wax.
| LAXATIVE
bisacodyl tablet, delayed release |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Heartland Pharma Co. (119127089) |
| Registrant - Geri-Care Pharmaceutical Corp (611196254) |
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.